both have been researched for their proposed affinity for receptors in the pituitary gland and other parts of the central nervous system
From reducing inflammation to supporting recovery in chronic and complex conditions, this conversation breaks down the science, the global treatment landscape, and what the future of healing could look like
Agliardi C, Guerini FR, Saresella M, et al
With its distinctive strategy for targeting receptorsnamely those receptive to GIP, GLP-1, and glucagonit stands out as a progressive option for the treatment of diabetes and obesity-related issues
You will likely be turned away if you have a history of pancreatitis (pancreas inflammation), a thyroid cancer called medullary thyroid carcinoma in your family, if you are pregnant, if your weight has changed by more than 11 lbs in the past 3 months, or if you are already taking a weight loss drug